Updated from 5:43 p.m. ESTDutch biopharmaceutical company Crucell (CRXL) said Wednesday it has been involved in talks that could lead to its acquisition by Wyeth (WYE).
Crucell Has Had Merger Talks With Wyeth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.